Research location

Grand Rapids

Michigan, United States

Published trials787
Site observations1,091
Linked trials published787
Page1 / 16

Research activity in Grand Rapids

Michigan, United States

CureCurrent currently publishes aggregate city-level research activity for this location: 787 trials and 1,091 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Grand Rapids

787 linked trials · page 1 of 16
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC TrialNCT07388524 · 2027-03-02 · 1 site observation
RECRUITING
Dose Optimization and Diagnostic Performance in Prostate Cancer (SPARROW [Staging Prostate Cancer With Advanced RM2 Radiotracer Oncologic Workup])NCT07831824 · 2026-09-30 · 1 site observation
RECRUITING
JUR-003 in Adult Patients With Metastatic Prostate CancerNCT07824349 · 2026-09-01 · 1 site observation
RECRUITING
Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)NCT07778316 · 2026-08-28 · 1 site observation
RECRUITING
A Study of JNJ-98768111 in Participants With Advanced Prostate CancerNCT07746713 · 2026-08-05 · 1 site observation
RECRUITING
DBC-664 in Adult Patients With Solid TumorsNCT07705035 · 2026-07-17 · 1 site observation
RECRUITING
Michigan Healthy Mom (MI-MOM) Pregnancy Improvement Web Application TrialNCT07213284 · 2026-07-15 · 1 site observation
RECRUITING
Phase 1 Study of a Self-amplifying RNA Vaccine (ITI-5000) in Stage 2-3 Triple Negative Breast CancerNCT07652242 · 2026-07-14 · 1 site observation
RECRUITING
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung CancerNCT07365241 · 2026-07-02 · 1 site observation
RECRUITING
A Study in Patients With Metastatic Castration-Resistant Prostate CancerNCT07719361 · 2026-07-01 · 1 site observation
RECRUITING
A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate CancerNCT07581184 · 2026-06-17 · 1 site observation
RECRUITING
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and ObesityNCT07567001 · 2026-05-11 · 1 site observation
RECRUITING
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast CancerNCT07214532 · 2026-05-08 · 1 site observation
RECRUITING
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid TumorsNCT07488676 · 2026-05-04 · 1 site observation
RECRUITING
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)NCT07611110 · 2026-05-04 · 1 site observation
RECRUITING
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid TumorsNCT07454642 · 2026-03-31 · 1 site observation
RECRUITING
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL TrialNCT07200830 · 2026-03-31 · 1 site observation
RECRUITING
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid TumorsNCT07189871 · 2026-02-23 · 1 site observation
RECRUITING
First-Time-in-Human Study of GSK5471713 in Adults With mCRPCNCT07332455 · 2026-02-10 · 1 site observation
RECRUITING
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid TumorsNCT07349537 · 2026-01-08 · 1 site observation
RECRUITING
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid TumorsNCT07361562 · 2025-12-30 · 1 site observation
RECRUITING
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid TumorsNCT07318805 · 2025-12-23 · 1 site observation
RECRUITING
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid TumorsNCT07444814 · 2025-12-19 · 1 site observation
RECRUITING
A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)NCT07244341 · 2025-12-03 · 1 site observation
RECRUITING
A Study to Assess the Adverse Events, Change in Disease Activity, and How Oral ABBV-711 Tablets Move Through the Body as a Monotherapy and in Combination With Intravenously Infused Budigalimab (ABBV-181), in Adults With Advanced Squamous TumorsNCT07241039 · 2025-11-20 · 1 site observation
RECRUITING
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell CarcinomasNCT07217171 · 2025-11-13 · 1 site observation
RECRUITING
A Study of LY4337713 in Participants With FAP-Positive Solid TumorsNCT07213791 · 2025-10-22 · 1 site observation
RECRUITING
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart FailureNCT07069738 · 2025-10-22 · 1 site observation
RECRUITING
A Study of ZW251 in Participants With Advanced Solid TumorsNCT07164313 · 2025-10-21 · 1 site observation
RECRUITING
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung CancerNCT07174583 · 2025-10-14 · 2 site observations
RECRUITING
A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate CancerNCT07192614 · 2025-09-30 · 1 site observation
RECRUITING
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus TrastuzumabNCT06876714 · 2025-09-17 · 2 site observations
RECRUITING
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid TumorsNCT07145255 · 2025-09-03 · 1 site observation
RECRUITING
Study of CP-383 in Patients With Advanced or Metastatic Solid TumorsNCT07030257 · 2025-08-27 · 1 site observation
RECRUITING
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid TumorsNCT07020117 · 2025-08-22 · 1 site observation
RECRUITING
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid TumorsNCT07085091 · 2025-08-18 · 1 site observation
RECRUITING
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant TumorsNCT07070232 · 2025-08-12 · 1 site observation
RECRUITING
A Study of LY4257496 in Participants With Cancer (OMNIRAY)NCT07114601 · 2025-08-06 · 1 site observation
RECRUITING
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid TumorsNCT07115043 · 2025-07-29 · 1 site observation
RECRUITING
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid TumorsNCT07094204 · 2025-07-25 · 1 site observation
RECRUITING
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.NCT06758401 · 2025-07-23 · 5 site observations
RECRUITING
Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)NCT06898515 · 2025-07-14 · 1 site observation
RECRUITING
E-Mindfulness Approaches for Living After Breast CancerNCT06748222 · 2025-06-27 · 1 site observation
RECRUITING
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary DiseaseNCT07082738 · 2025-06-27 · 1 site observation
RECRUITING
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and ObesityNCT07037459 · 2025-06-25 · 1 site observation
RECRUITING
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)NCT06925737 · 2025-05-13 · 1 site observation
RECRUITING
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast CancerNCT06827236 · 2025-04-23 · 1 site observation
RECRUITING
A Study of MT-4561 in Patients With Various Advanced Solid TumorsNCT06943521 · 2025-04-18 · 1 site observation
RECRUITING
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast CancerNCT06790693 · 2025-04-09 · 1 site observation
RECRUITING
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT TrialNCT06498635 · 2025-04-01 · 2 site observations
RECRUITING

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.